Novel tripeptide RKH derived from Akkermansia muciniphila protects against lethal sepsis.

Gut(2023)

Cited 0|Views36
No score
Abstract
We revealed that a novel tripeptide, RKH, derived from live AKK, may act as a novel endogenous antagonist for TLR4. RKH may serve as a novel potential therapeutic approach to combat lethal sepsis after successfully translating its efficacy into clinical practice.
More
Translated text
Key words
sepsis, probiotics, macrophages, inflammation, intestinal microbiology
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined